Softonic achieves best results in a decade, driven by diversification and sustainable growth
BARCELONA, Spain, March 06, 2025 (GLOBE NEWSWIRE) -- Softonic, the leading global platform for secure software distribution, has reported €28.4 million in revenue for 2024, its highest since 2014 and a 16% increase from 2023. The company has nearly doubled in size since 2020, marking a major milestone in its turnaround and sustained growth.
Softonic's EBITDA surged over 150% year-over-year, driven by a refined revenue mix, improved team productivity through smarter work practices, and enhanced operational efficiency.
A key growth driver has been its diversification strategy. While maintaining its market-leading 25% share in B2C, Softonic expanded in B2B with the acquisition of Appvizer, a European B2B SaaS distribution expert. This acquisition enabled Softonic to access a new customer segment, accounting for approximately 10% of the company's total revenue in 2024.
Another key factor is the strength of its primary business model. Softonic.com, the core platform, generated €22.9 million in revenue, up 11%, while sector partnerships grew 4%. Since taking over Download.com, traffic and revenue have doubled, and other business lines contributed 6%.
Additionally, Softonic's company-wide strategic programme 'Above and Beyond', launched in 2023, reinforced its approach by defining strategic priorities, identifying key initiatives, strengthening the company's culture, and improving processes and tools to enhance efficiency. It also supports the development of high-performance teams.
Fiona Garvey, CEO of Softonic, said: '2024 has been a pivotal year for our company. Not only have we achieved our highest revenue in a decade, but we have also entered the B2B sector through strategic acquisitions and partnerships. By diversifying our business and optimising our operations, we have built a more resilient, future-ready company, positioning ourselves for continued leadership in software distribution with sustained growth.'
Looking ahead, the company will deepen its B2B presence by integrating dedicated content within Softonic.com and complementing the established offerings on Appvizer. The company also plans strategic acquisitions and partnerships and will continue optimising its core operations, enhancing efficiency, and improving user experience.
Innovation will remain key, with plans to explore new opportunities in the mobile segment to diversify revenue streams and expand support for developers. Softonic aims to help developers reach wider audiences and maximise their impact by providing better tools and visibility.
About Softonic
Softonic is a leading technology company specialising in secure software distribution. The firm operates the world's leading secure software distribution platform Softonic.com. Currently available in 18 languages, the platform categorises, evaluates, and distributes over 1 million Windows, Android, and Mac programmes and solutions worldwide. Every month, over 75 million people use Softonic.com due to its robust quality control checks, which help users download virus-free software.
Founded in Barcelona in 1997, Softonic is also the driving force behind other initiatives, such as GHacks, a portal for IT users, a technology news platform. In July 2024, the company acquired Appvizer, which specialises in B2B software design to support professional growth. Softonic has expanded its workforce of over 110 employees representing over 22 nationalities.
Contact:
F.awoyemi@romanrm.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
22 minutes ago
- CNBC
See interesting case for Europe if they can get their act together: BNP Paribas AM
Carmine De Franco of BNP Paribas Asset Management believes European valuations are attractive compared to the U.S., with sector strength lying in health care and defense, instead of technology.
Yahoo
42 minutes ago
- Yahoo
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited ('RenaissThera'), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR). GIPR, an incretin receptor, is a validated target for peptide-based parenteral therapies where both stimulation and inhibition has shown efficacy in treating obesity and its co-morbidities. RenaissThera is developing novel, oral small molecules, both agonists and antagonists, as a more affordable and convenient alternative aiming to expand access for underserved populations in the global obesity market projected to reach USD 38 billion by 2032. Oral small molecules are more economical to manufacture and distribute than peptide-based obesity drugs. These molecules were designed and screened using proprietary AI and ML based platforms, followed by demonstrating in-vitro activity in cell lines and in-vivo activity to impact GIPR in mice to yield 'Hits'. RenaissThera now is advancing these Hits to the Lead optimization program to select candidates for pre-IND studies. RenaissThera is filing 'Composition of Matter' and utility patents for these oral novel small molecule GIPR modulators and continues to expand its innovation portfolio targeting GIP, GLP-1, and apelin receptors in obesity and diabetes. Its AI-powered Innovation Platform, integrating GenAI and machine learning tools, is accelerating the design and optimization of novel small molecules. 'We are grateful to our investors and collaborators for supporting us in reaching this milestone. Our team is focused on pushing candidates toward IND-readiness next year and we are in active discussions with potential pharma partners and investors interested in our obesity program,' said Meena, MD, CEO of RenaissThera. RenaissThera's progress was enabled through its collaboration with VedTechBio Research Private Limited which enabled access to its Agentic AI platform RxAgentAI and discovery expertise. 'We are very pleased with the outcomes of our collaboration with RenaissThera. This milestone further validates our platform and capabilities across key therapeutic areas including obesity, Type 2 diabetes, oncology, and inflammation,' said VedTechBio's Managing Director Sudhir Nagarajan. About RenaissThera RenaissThera is a Bengaluru-based biotech company developing affordable, AI-powered novel small-molecule therapies for high-unmet-need diseases like obesity and diabetes. Its goal is to innovate for underserved populations and expand global access to novel therapies. It leverages India's CRO ecosystem for early-stage R&D to deliver globally relevant innovation. For more information Please contact: Media: Lakshmi Ramakrishna lramakrishna@ Investor & Partnership: Ramkesh Meena bd@
Yahoo
an hour ago
- Yahoo
Threads Continues to See Strong Download Momentum in May
This story was originally published on Social Media Today. To receive daily news and insights, subscribe to our free daily Social Media Today newsletter. Threads continues to hold its place in the app download charts, with Meta's Twitter replicant remaining at 8th spot in the list, and seeing an increase in overall download volume in May. As you can see in this latest ranking data from AppFigures, Threads saw 23 million downloads across iOS and Android in May, which is up from 22 million April, and at the same level that the app saw in March. Threads is now up to 350 million monthly active users, and gaining quickly on X, which reported in March that it's now up to 600 million monthly actives, an increase of 50 million year-over-year. Though those figures are somewhat questionable, considering that X has also down 15% on overall European usage since Elon Musk took over at the app, as per its official DSA reporting data. As a private company, X is not obligated to share auditable usage data, but it does have to provide such for Europe, and given that its EU audience is down, it would be surprising if X is somehow gaining significant momentum in other markets, and not only replacing its lost EU users, but also exceeding its previous audience. But even so, Threads is clearly doing something right, as it continues to gain in download numbers, and attract more people to the app. The platform is increasingly putting more focus on real-time news, while it's also enhancing its live event elements, including sports, as it seeks to supplant X as the top platform for in-the-moment engagement. Looking at other app movements, TikTok remains popular, staying in the top three for downloads throughout the year thus far, and switching places back and forth with Instagram for second spot behind ChatGPT. Facebook and WhatsApp have also held their positions in the list, while Snapchat is also still clinging to the top 10. Though it is also interesting to consider Snap's relative challenges in this respect, by comparing the performance of these apps. One of Snapchat's key problems is that while it remains a key utility for younger audiences, it doesn't maintain that hold on older users, and as users age up, it loses them to other apps. That's somewhat reflected in the data, with Snapchat seeing strong download volume, but sitting on fewer users, at 900 million monthly actives, and 460 million daily users. IG, Facebook and TikTok have all surpassed the billion user milestone, and it's interesting to see Snap remaining at lower usage levels, despite relative download interest. It's another reminder of Snap's growth challenges, and how it needs to evolve in line with its audience. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
